Home Cart 0 Sign in  
X

[ CAS No. 1071727-78-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 1071727-78-0
Chemical Structure| 1071727-78-0
Chemical Structure| 1071727-78-0
Structure of 1071727-78-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1071727-78-0 ]

Related Doc. of [ 1071727-78-0 ]

Alternatived Products of [ 1071727-78-0 ]

Product Details of [ 1071727-78-0 ]

CAS No. :1071727-78-0 MDL No. :MFCD28975314
Formula : C9H10N2O Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 162.19 Pubchem ID :-
Synonyms :

Calculated chemistry of [ 1071727-78-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.44
TPSA : 34.48 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.22 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.91
Log Po/w (XLOGP3) : 1.51
Log Po/w (WLOGP) : 1.38
Log Po/w (MLOGP) : 0.71
Log Po/w (SILICOS-IT) : 2.39
Consensus Log Po/w : 1.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.1
Solubility : 1.29 mg/ml ; 0.00793 mol/l
Class : Soluble
Log S (Ali) : -1.84
Solubility : 2.33 mg/ml ; 0.0144 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.0
Solubility : 0.16 mg/ml ; 0.000989 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.53

Safety of [ 1071727-78-0 ]

Signal Word:Danger Class:4.1
Precautionary Statements:P210-P240-P241-P280-P370+P378 UN#:1325
Hazard Statements:H228 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1071727-78-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1071727-78-0 ]
  • Downstream synthetic route of [ 1071727-78-0 ]

[ 1071727-78-0 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 31170-78-2 ]
  • [ 593-56-6 ]
  • [ 1071727-78-0 ]
YieldReaction ConditionsOperation in experiment
68% With triethylamine In methanolHeating / reflux 5,6-Dihydro-[1]pyrindin-7-one O-methyl-oxime: Methoxylamine hydrochloride (6.20 g, 74.23 mmol) was added to a solution of 5,6-dihydro-[1]pyrindin-7-one (4.96 g, 37.25 mmol) in MeOH and triethylamine (10.4 mL, 74.62 mmol) was added. After refluxing overnight, the reaction mixture was cooled to room temperature and extracted with EtOAc (3.x.200 mL). The combined organic extracts were washed with H2O (3.x.200 mL), brine (1.x.200 mL), dried over MgSO4 and concentrated. Purification by column chromatography using hex: Et2O (4:1) as the eluant afforded 4.10 g (68percent yield) of the title oxime.31 g (96.5percent yield) of the title compound. Spectroscopic data: 1H NMR (300 MHz, CDCl3) δ 2.90-2.96 (m, 2H), 2.99-3.07 (m, 2H), 4.08 (s, 3H), 7.21 (q, J=4.69, 2.93 Hz, 1H), 7.63 (d, J=7.92 Hz, 1H), 8.55 (d, J=4.69 Hz, 1H).
Reference: [1] Patent: US2008/255239, 2008, A1, . Location in patent: Page/Page column 32
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 3, p. 392 - 395
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 1071727-78-0 ]

Other Aromatic Heterocycles

Chemical Structure| 230-07-9

[ 230-07-9 ]

4,7-Phenanthroline

Similarity: 0.74

Chemical Structure| 91804-75-0

[ 91804-75-0 ]

1,10-Phenanthroline-5-carbaldehyde

Similarity: 0.68

Chemical Structure| 41598-71-4

[ 41598-71-4 ]

6,7-Dihydro-5H-cyclopenta[b]pyridin-7-ol

Similarity: 0.65

Chemical Structure| 36556-06-6

[ 36556-06-6 ]

5,6,7,8-Tetrahydroisoquinoline

Similarity: 0.64

Chemical Structure| 31170-78-2

[ 31170-78-2 ]

5H-Cyclopenta[b]pyridin-7(6H)-one

Similarity: 0.62